Alx Oncology Holdings (ALXO) Total Current Liabilities (2019 - 2026)

Alx Oncology Holdings has reported Total Current Liabilities for 8 years, with the latest figure at $20.2 million in Q1 2026.

• Quarterly Total Current Liabilities rose 7.66% year-over-year to $20.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $20.2 million (up 7.66% YoY) and the FY2025 annual result came in at $24.6 million, up 32.72% from the prior year.
• Total Current Liabilities declined to $20.2 million in Q1 2026 per ALXO's latest filing, from $24.6 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $38.4 million in Q2 2024 and troughed at $15.3 million in Q1 2022.
• A 5-year average of $25.6 million and a median of $24.6 million in 2025 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 118.81% in 2024, then slumped 50.98% in 2025.
• Over 5 years, Total Current Liabilities stood at $28.3 million in 2022, then advanced by 27.1% to $36.0 million in 2023, then plunged by 48.61% to $18.5 million in 2024, then surged by 32.72% to $24.6 million in 2025, then retreated by 17.82% to $20.2 million in 2026.
• According to Business Quant data, Total Current Liabilities over the past three periods registered $20.2 million, $24.6 million, and $27.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.